📰 Life Sciences Ltd News
Page 4 - Life Sciences Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciences Ltd. Real-time updates on events, politics, business and more.
August 21, 2023
StockNews.com initiated coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report published on Thursday. The brokerage issued a buy rating on the stock. A number of other equities analysts have also issued reports on WVE. HC Wainwright reaffirmed a buy rating and issued a $8.00 target price on shares of […]
August 17, 2023
Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares added almost 55% in pre-market trading on Tuesday after the biotechnology company announced that its...
August 8, 2023
Leerink Partnrs restated their market perform rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note published on Friday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Wave Life Sciences’ Q1 2024 earnings at ($0.23) EPS, Q2 2024 earnings at ($0.23) EPS, Q3 2024 earnings at ($0.23) EPS and Q4 […]
July 25, 2023
Major players in the enzyme replacement therapy market are Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc.,...
July 18, 2023
Tiziana Life Sciences Ltd (NASDAQ:TLSA – Get Free Report) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totalling 100,700 shares, a drop of 51.4% from the June 15th total of 207,400 shares. Based on an average trading volume of 183,600 shares, the short-interest […]
July 10, 2023
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated with...
July 9, 2023
Raymond James started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $7.00 price target on the stock. Several other equities research analysts have also recently commented on WVE. Jefferies Financial Group cut shares of Wave […]
July 7, 2023
Equities research analysts at Raymond James assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $7.00 price target on the stock. Raymond James’ price target indicates a potential upside of 83.73% from the stock’s […]
July 5, 2023
Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and 
July 3, 2023
SPC Life Sciences has received approval from the Securities and Exchange Board of India (Sebi) to raise funds through an initial public offering (IPO). The IPO will consist of fresh equity shares worth Rs 300 crore and an Offer For Sale of 89.39 lakh equity shares by the companys promoter. The company may also consider a pre-IPO placement of up to Rs 60 crore. Proceeds from the IPO will be used to pay debt, support working capital needs, fund capital expenditure, and expand product offerings.